Profusa (PFSA) Common Equity (2021 - 2026)
Profusa's (PFSA) quarterly Common Equity came in at -$28.2 million in Q1 2026, up 76.87% year-on-year from -$15.9 million in Q1 2025, and down 5.78% quarter-over-quarter from -$26.7 million in Q4 2025.
Profusa (PFSA) Common Equity (2021 - 2026) Analysis & Trends
Profusa's Common Equity history runs 6 years deep, the most recent figure standing at -$28.2 million for Q1 2026.
- On a quarterly basis, Common Equity rose 76.87% year-over-year to -$28.2 million in Q1 2026; TTM through Mar 2026 was -$28.2 million, a 76.87% increase from a year earlier, with the FY2025 full-year figure at -$26.7 million, up 77.64% from the prior year.
- Common Equity retreated to -$28.2 million in Q1 2026 per PFSA's latest filing, from -$26.7 million in the prior quarter.
- Across five years, Common Equity topped out at -$373856.0 in Q3 2022 and bottomed at -$124.2 million in Q2 2025.
- The 5-year median for Common Equity is -$28.2 million (2026), against an average of -$54.2 million.
- Across the five-year window, Common Equity surged 89.52% in 2022 and slumped 17656.3% in 2023, its largest moves.
- Year by year, Common Equity stood at -$619476.0 in 2022, then slumped by 17656.3% to -$110.0 million in 2023, then fell by 8.37% to -$119.2 million in 2024, then surged by 77.64% to -$26.7 million in 2025, then fell by 5.78% to -$28.2 million in 2026.
- Per Business Quant, the three latest PFSA Common Equity figures stand at -$28.2 million (Q1 2026), -$26.7 million (Q4 2025), and -$34.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | -28.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.20 Mn |
| Dec 31, 2025 | -26.66 Mn |
| Sep 30, 2025 | -33.96 Mn |
| Jun 30, 2025 | -124.18 Mn |
| Mar 31, 2025 | -121.92 Mn |
| Dec 31, 2024 | -119.21 Mn |
| Sep 30, 2024 | -116.96 Mn |
| Jun 30, 2024 | -114.47 Mn |
| Mar 31, 2024 | -112.06 Mn |
| Dec 31, 2023 | -110.00 Mn |
| Sep 30, 2023 | -3.48 Mn |
| Jun 30, 2023 | -2.87 Mn |
| Mar 31, 2023 | -3.31 Mn |
| Dec 31, 2022 | -619,476.00 |
| Sep 30, 2022 | -373,856.00 |
| Jun 30, 2022 | -1.12 Mn |
| Mar 31, 2022 | -2.20 Mn |
| Dec 31, 2021 | -5.91 Mn |